Therapy for the treatment of disease
AssigneeTheravida, Inc.
InventorMehdi Paborji
Life of this patent
Estimating the term…
Abstract
Disclosed herein are pharmaceutical compositions comprising various combinations of an antimuscarinic or an anticholinergic agent, a compound that causes stimulation of salivary glands, and a compound that relieves constipation. Also disclosed are methods of treating a patient suffering from overactive bladder comprising administering to the patient the above pharmaceutical composition.
Claims20
A method of improving quality of sleep in a patient suffering from overactive bladder, the method comprising
- identifying a patient in need thereof, and
- administering to the patient a therapeutically effective amount of oxybutynin or tolterodine, or a free base thereof or a pharmaceutically acceptable salt thereof, and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof,
- whereby the quality of sleep in the patient is improved.
A method of improving quality of sleep in a patient suffering from overactive bladder, the method comprising
- identifying a patient in need thereof, and
- administering to the patient oxybutynin, or a free base thereof or a pharmaceutically acceptable salt thereof, at a dose of between 0.5 mg to 2 mg and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof at a dose of between 0.05 mg to 50 mg,
- whereby the quality of sleep in the patient is improved.
A method of improving quality of sleep in a patient suffering from overactive bladder, the method comprising
- identifying a patient in need thereof, and
- administering to the patient tolterodine, or a free base thereof or a pharmaceutically acceptable salt thereof, at a dose of between 0.05 mg to 50 mg and pilocarpine, or a free base thereof or a pharmaceutically acceptable salt thereof at a dose of between 0.05 mg to 50 mg,
- whereby the quality of sleep in the patient is improved.
Dependencies are inferred from the claim text.